// App-Quantinova.ai

59 : DetermaIO (IO score) is associated with efficacy of ICI monotherapy in advanced NSCLC patients: a retrospective BC Cancer study

Researchers

Presenter

  • David Saltman

Principal Investigators

  • Nicole Croteau

  • Heather Lockyer

  • Rob Seitz

  • Frank McMahon

  • Jeremy Spille

  • Andrea Dickey

  • Jordan Jennings

  • Matthew Varga

  • Kimberly McGregor

  • Tyler Nielsen

  • David Hout

  • Brock Schweitzer

  • Douglas Ross

  • David Gandara

Medical Centers

  • BC Cancer, Victoria, Canada

  • The University of British Columbia, Vancouver, BC, Canada

  • University of California, Davis,Sacramento,Estados Uni

  • Oncocyte Corporation, Nashville, TN, USA

Locations

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

  • Non Small Cell Lung cancer

Biomarkers

  • Programmed death-ligand 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved